Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Grounded Lithium (GRDAF)
OTHER OTC:GRDAF
Holding GRDAF?
Track your performance easily
GRDAF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.02 - $0.10
Previous Close$0.05
Volume80.05K
Average Volume (3M)33.98K
Market Cap
$3.26M
Enterprise Value$3.00M
Total Cash (Recent Filing)C$430.04K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta-0.65
Next Earnings
Nov 20, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding78,279,227
10 Day Avg. Volume64,339
30 Day Avg. Volume33,976
Standard Deviation0.24
R-Squared0.03
Alpha-0.00803
Financial Highlights & Ratios
Price to Book (P/B)1.59
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-14.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Grounded Lithium News
PremiumCompany Announcements
Grounded Lithium Launches 2024 Program with Stantec
PremiumCompany Announcements
Grounded Lithium Boosts Project with $4.5M Denison Mines Funding
PremiumCompany Announcements
Grounded Lithium Reveals Promising Q2 2024 Results
PremiumCompany Announcements
Grounded Lithium Optimistic with Q1 2024 Results
PremiumCompany Announcements
Grounded Lithium Corp: A Year of Strategic Triumphs
PremiumCompany Announcements
Grounded Lithium Strengthens Partnerships and Rewards TeamOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
0.04% Other Institutional Investors
99.96% Public Companies and
Individual Investors
GRDAF FAQ
What was Grounded Lithium’s price range in the past 12 months?
Grounded Lithium lowest stock price was $0.02 and its highest was $0.10 in the past 12 months.
What is Grounded Lithium’s market cap?
Currently, no data Available
When is Grounded Lithium’s upcoming earnings report date?
Grounded Lithium’s upcoming earnings report date is Nov 20, 2024 which is in 7 days.
How were Grounded Lithium’s earnings last quarter?
Grounded Lithium released its earnings results on Aug 21, 2024. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.
Is Grounded Lithium overvalued?
According to Wall Street analysts Grounded Lithium’s price is currently Overvalued.
Does Grounded Lithium pay dividends?
Grounded Lithium does not currently pay dividends.
What is Grounded Lithium’s EPS estimate?
Grounded Lithium’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Grounded Lithium have?
Grounded Lithium has 70,889,946 shares outstanding.
What happened to Grounded Lithium’s price movement after its last earnings report?
Grounded Lithium reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 50%.
Which hedge fund is a major shareholder of Grounded Lithium?
Currently, no hedge funds are holding shares in GRDAF
---
Grounded Lithium Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-30.88%
12-Months-Change
Fundamentals
Return on Equity
-84.01%
Trailing 12-Months
Asset Growth
-30.68%
Trailing 12-Months
Company Description
Grounded Lithium
Canadian International Pharma Corp is a Canada based pharmaceutical company. It is engaged in generic drug manufacturing and distribution business. The pharmaceutical products of the company are Acetaminophen, Betamethasone, Biperiden, Tetracycline, Simvastatin, Pediatric Multivitamin, and others. Its nutraceutical products offered by the group are Activated Charcol capsules, Bilberry capsules, Collatol capsules, Fish Oil Softgels, Melatonin Softgels, Wild Salmon Oil Softgels, and others. The company also provides medications with a private label based on client requests. In addition, it also offers primary and secondary packaging for tablet, capsules and other forms of medications.
---
Technical Analysis
---